Co-Target(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T61657 | Target Info | |||
| Target Name | Retinoic acid receptor beta (RARB) | ||||
| Synonyms |
RAR-epsilon; RAR-beta; Nuclear receptor subfamily 1 group B member 2; NR1B2; HBV-activated protein; HAP
Click to Show/Hide
|
||||
| Target Type | Successful Target | ||||
| Gene Name | RARB | ||||
| Biochemical Class | Nuclear hormone receptor | ||||
| UniProt ID | |||||
| Co-Targets of This Target | Top | |||||
|---|---|---|---|---|---|---|
| Co-Target Name | Retinoic acid receptor gamma (RARG) | Successful Target | ||||
| UniProt ID | RARG_HUMAN | |||||
| Gene Name | RARG | |||||
| Synonyms |
RAR-gamma; Nuclear receptor subfamily 1 group B member 3; NR1B3
Click to Show/Hide
|
|||||
| Representative Drug(s) | Alitretinoin | Drug Info | Ki = 1 nM | Click to Show More | [1] | |
| 2 | Tamibarotene | Drug Info | EC50 = 591 nM | [5] | ||
| Co-Target Name | Retinoic acid receptor RXR-alpha (RXRA) | Successful Target | ||||
| UniProt ID | RXRA_HUMAN | |||||
| Gene Name | RXRA | |||||
| Synonyms |
Retinoid X receptor alpha; RXRalpha; Nuclear receptor subfamily 2 group B member 1; NR2B1
Click to Show/Hide
|
|||||
| Representative Drug(s) | Alitretinoin | Drug Info | EC50 = 1.5 nM | [2] | ||
| Co-Target Name | Retinoic acid receptor RXR-beta (RXRB) | Successful Target | ||||
| UniProt ID | RXRB_HUMAN | |||||
| Gene Name | RXRB | |||||
| Synonyms |
Retinoid X receptor beta; Nuclear receptor subfamily 2 group B member 2; NR2B2
Click to Show/Hide
|
|||||
| Representative Drug(s) | Alitretinoin | Drug Info | EC50 = 2.6 nM | [3] | ||
| Co-Target Name | Retinoic acid receptor RXR-gamma (RXRG) | Successful Target | ||||
| UniProt ID | RXRG_HUMAN | |||||
| Gene Name | RXRG | |||||
| Synonyms |
Retinoid X receptor gamma; Nuclear receptor subfamily 2 group B member 3; NR2B3
Click to Show/Hide
|
|||||
| Representative Drug(s) | Alitretinoin | Drug Info | IC50 = 4 nM | [4] | ||
| Co-Target Name | Retinoic acid receptor alpha (RARA) | Clinical trial Target | ||||
| UniProt ID | RARA_HUMAN | |||||
| Gene Name | RARA | |||||
| Synonyms |
RAR-alpha; RAR alpha; Nuclear receptor subfamily 1 group B member 1; NR1B1
Click to Show/Hide
|
|||||
| Representative Drug(s) | Tamibarotene | Drug Info | Ki = 6.5 nM | Click to Show More | [1] | |
| 2 | Alitretinoin | Drug Info | IC50 = 7 nM | [4] | ||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J Med Chem. 1997 Dec 19;40(26):4222-34. | ||||
| REF 2 | Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. J Med Chem. 2001 Jul 5;44(14):2298-303. | ||||
| REF 3 | Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem. 1995 Aug 18;38(17):3368-83. | ||||
| REF 4 | Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem. 1994 Feb 4;37(3):408-14. | ||||
| REF 5 | Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives. J Med Chem. 2010 Oct 14;53(19):6779-810. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.